HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A prospective randomized comparison between laparoscopic and laparotomic approaches in women with early stage endometrial cancer: a focus on the quality of life.

AbstractOBJECTIVE:
This study was undertaken to compare the quality of life (QoL) in women with early stage endometrial cancer treated with 2 different surgical approaches.
STUDY DESIGN:
Eighty-four women with clinical stage I endometrial cancer were enrolled in a prospective randomized controlled trial design and treated with laparoscopic or laparotomic approach. Another 40 women matched for demographic characteristics were studied as controls. In patients, before and after surgery, and in their matched controls, QoL was evaluated by using the Short-Form Healthy Survey (SF-36) and the climacteric symptoms using the Kupperman Index (KI).
RESULTS:
After randomization, no difference was detected in data recorded between the groups. At entry, QoL was similar in both treatment groups but significantly (P < .05) worse in comparison with controls. Throughout the study, QoL was significantly (P < .05) higher in laparoscopic group versus laparotomic group. After KI adjustment our data did not change.
CONCLUSION:
In early stage endometrial cancer, the laparoscopic approach provides significant benefits compared with laparotomy in terms of QoL.
AuthorsFulvio Zullo, Stefano Palomba, Tiziana Russo, Angela Falbo, Marilena Costantino, Achille Tolino, Errico Zupi, Piersandro Tagliaferri, Salvatore Venuta
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 193 Issue 4 Pg. 1344-52 (Oct 2005) ISSN: 1097-6868 [Electronic] United States
PMID16202724 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Topics
  • Endometrial Neoplasms (pathology, surgery)
  • Female
  • Humans
  • Laparoscopy
  • Laparotomy
  • Middle Aged
  • Neoplasm Staging
  • Prospective Studies
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: